Day: September 28, 2020

HOUSTON, Sept. 28, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual conferences.Conference Details:Jefferies Cell Therapy Virtual SummitDate/Time: Monday, October 5, 2020 at 11:30 a.m. EDTFormat: Fireside chat2020 Virtual Cell & Gene Meeting on the MesaDate: Monday, October 12, 2020 – Friday, October 16, 2020Format: Prerecorded company presentation will be available for registered attendees to view on-demand throughout the entirety of the conference. Please visit www.meetingonthemesa.com for full information including registration.A live webcast of the fireside chat at the Jefferies Cell Therapy Summit may be accessed from the Events & Presentation...

SHANGHAI and SAN FRANCISCO, Sept. 28, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) under the stock code “9688” and the closing of its previously-announced Hong Kong secondary listing (the “Hong Kong Secondary Listing”) of 10,564,050 new ordinary shares (the “Offer Shares” or “Shares”) which comprises an international offering (the “International Offering”) and a Hong Kong public offering (the “Hong Kong Public Offering,” and together with the International Offering, the “Offering”). The final offer price for both the International Offering and the Hong Kong Public Offering (the “Offer Price”) has...

NEW YORK, NY, Sept. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that it has become a vendor to Wawa, Inc. (“Wawa”), an American chain of convenience stores and gas stations located along the East Coast of the United States. The Company has already presented its Tauri-Gum™ product line to the Wawa Purchasing Network. On Friday, September 25, 2020, the Company signed its Vendor Agreement with Wawa, Inc.Currently, Wawa operates more than 800 stores across six states and Washington, D.C.  The most...

GUANGZHOU, China, Sept. 28, 2020 (GLOBE NEWSWIRE) — Puyi Inc. (“Puyi” or the “Company”) (NASDAQ: PUYI), a leading third-party wealth management service provider in China focusing on mass affluent and emerging middle class population, today announced that it has filed its annual report on Form 20-F, which contains its audited financial statements for the fiscal year ended June 30, 2020 (“2020 Annual Report”), with the U.S. Securities and Exchange Commission (the “SEC”) on September 28, 2020. The 2020 Annual Report can be accessed on the SEC’s website at http://www.sec.gov as well as on the Investor Relations page of the Company’s website at http://ir.puyiwm.com/financial-information/SEC-filings. Hard copies of the 2020 Annual Report are available and free of charge to its shareholders upon request.Senior management will host a combined...

PLYMOUTH, Mich., Sept. 28, 2020 (GLOBE NEWSWIRE) — Perceptron, Inc. (NASDAQ: PRCP), a leading global provider of 3D automated metrology solutions and coordinate measuring machines, today announced results for the three and twelve months ended June 30, 2020.PERFORMANCE SUMMARY“Our business performed ahead of expectations during the fiscal fourth quarter,” stated Jay Freeland, Chairman and Interim CEO of Perceptron.  “Bookings increased 62.4% on a sequential basis during the period, driven by increased customer demand in Asia and Europe.  Both China and Germany reported strong sequential and year-over-year growth in bookings, as customers returned to work following the expiration of COVID-19 shelter-in-place orders.”“Operations at our Asian facilities resumed in March, while Europe and the U.S. restarted in mid-May,” continued Freeland. ...

BOSTON and LONDON, Sept. 28, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to OTL-203, an investigational ex vivo autologous hematopoietic stem cell (HSC) gene therapy in development for the treatment of mucopolysaccharidosis type I (MPS-I) at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy.“We are encouraged by EMA’s decision to grant PRIME designation to OTL-203, which was based on an initial clinical assessment of data supporting the potential benefit of our HSC gene therapy for patients with MPS-IH beyond the current standard of care,” said Anne Dupraz-Poiseau, PhD., chief regulatory officer of Orchard. “In 2021, we look forward to building upon...

TORONTO, Sept. 28, 2020 (GLOBE NEWSWIRE) — Global Atomic Corporation (“Global Atomic” or the “Company”), (TSX: GLO, FRANKFURT: G12, OTCQX: GLATF) announced today that the Company has submitted the Mining Permit Application for its Dasa Uranium Project in Niger, as planned.Global Atomic in Niger and History of the Dasa Project:Global Atomic began negotiations with the Government of the Republic of Niger in 2005. In 2006, 4 permits were granted and in 2007 an additional two permits were granted. Field activities commenced during 2006.The Company has discovered four deposits on four permits, the most significant being the Dasa Project on the Adrar Emoles 3 permit in 2010.Since operations began in Niger, in excess of US$50 million has been spent on the exploration and development of these deposits.The Dasa Project is a Tier 1 asset,...